Abstract #4582
Dynamic Contrast Enhanced (DCE)-MRI and Circulating Angiogenic Factors for Monitoring of Antiangiogenic Effect of Bevacizumab in Colorectal Cancer Liver Metastasis
Bio Joo 1 , Mi-Suk Park 1 , Yeo-Eun Kim 1 , and Sang-Joon Shin 2
1
Department of Radiology and Research
Institute of Radiological Science, Yonsei University
College of, Seoul, Korea,
2
Cancer
Metastasis Research Center, Yonsei University College of
Medicine, Seoul, Korea
We assessed the clinical outcomes of colorectal cancer
liver metastasis (CRCLM) patients treated with
Bevacizumab plus FOLFOX by Dynamic Contrast Enhanced
(DCE)-MR imaging and plasma cytokines and angiogenic
factors (CAFs). Significant changes in DCE-MRI and CAFs
on 3 day after bevacizumab monotherapy proved
anti-angiogenic effect of bevacizumab monotherapy.
Higher baseline iAUC60 and early reduction of Ktrans
could predict longer PFS in the patients with CRCLM.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
